Anticoagulant treatment in German family practices - Screening results from a cluster randomized controlled trial

BMC Family Practice

Volumn 15, Issue 1, 2014, Pages

  Ulrich, Lisa R ^a   Mergenthal, Karola ^a   Petersen, Juliana J ^a   Roehl, Ina ^a   Rauck, Sandra ^a   Kemperdick, Birgit ^a   Schulz Rothe, Sylvia ^a   Berghold, Andrea ^b   Siebenhofer, Andrea ^a  

^a GOETHE UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Cluster randomization; Family practice; Health services research; Oral anticoagulation

Indexed keywords

ANTICOAGULANT AGENT; APIXABAN; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE; COUMARIN DERIVATIVE; DABIGATRAN; MORPHOLINE DERIVATIVE; PYRAZOLE DERIVATIVE; PYRIDONE DERIVATIVE; RIVAROXABAN; THIOPHENE DERIVATIVE;

AGED; ANALOGS AND DERIVATIVES; ATRIAL FIBRILLATION; COMPLICATION; FEMALE; GENERAL PRACTICE; GERMANY; HEALTH CARE QUALITY; HEART DISEASES; HEART VALVE PROSTHESIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; MASS SCREENING; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PULMONARY EMBOLISM; STANDARDS; STATISTICS AND NUMERICAL DATA; STROKE; THROMBOEMBOLISM; THROMBOSIS; VENOUS THROMBOEMBOLISM; VERY ELDERLY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; BENZIMIDAZOLES; BETA-ALANINE; COUMARINS; FAMILY PRACTICE; FEMALE; GERMANY; GUIDELINE ADHERENCE; HEART DISEASES; HEART VALVE PROSTHESIS; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MASS SCREENING; MIDDLE AGED; MORPHOLINES; PRACTICE GUIDELINES AS TOPIC; PROCESS ASSESSMENT (HEALTH CARE); PULMONARY EMBOLISM; PYRAZOLES; PYRIDONES; STROKE; THIOPHENES; THROMBOEMBOLISM; THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 84925884678     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/s12875-014-0170-0     Document Type: Article

References (22)

1. Guyatt GH: Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines. Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 2012, 141:53S.
2. Hua TD, Vormfelde SV, Abed MA, Schneider-Rudt H, Sobotta P, Chenot JF: Orale Antikoagulation in der Hausarztpraxis. [Oral Anticoagulation Therapy in Family Medicine]. Z Allg Med 2010, 10:382-389.
3. Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P, Goette A, Lewalter T, Ravens U, Meinertz T, Breithardt G, Steinbeck G: The registry of the German competence NETwork on atrial fibrillation: patient characteristics and initial management. Europace 2009, 11:423-434.
4. Lip GY, Golding DJ, Nazir M, Beevers DG, Child DL, Fletcher RI: A survey of atrial fibrillation in general practice: the West Birmingham atrial fibrillation project. Br J Gen Pract 1997, 47:285-289.
5. Saal K, Hofmann B, Blauth E, Rohe J, Beyer M, Harder S, Gerlach FM: Analyse des Behandlungsprozesses bei der oralen Antikoagulationstherapie zur Identifikation von Sicherheitsproblemen in der hausärztlichen Versorgung [Identifying safety problems in the General Practice - analysis of the treatment process of oral anticoagulation therapy]. Z Allg Med 2009, 85:148-155.
6. Heneghan C, Ward A, Perera R, Bankhead C, Fuller A, Stevens R, Bradford K, Tyndel S, Alonso-Coello P, Ansell J, Beyth R, Bernardo A, Christensen TD, Cromheecke M, Edson RG, Fitzmaurice D, Gadisseur APA, Garcia-Alamino JM, Gardiner C, Hasenkam M, Jacobson A, Kaatz S, Kamali F, Khan TI, Knight E, Körtke H, Levi M, Matchar DB, Menéndez-Jándula B, Rakovac I, et al: Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet 2012, 379:322-334.
7. Siebenhofer A, Jeitler K, Horvath K, Habacher W, Schmidt L, Semlitsch T: Self-management of oral anticoagulation. Dtsch Arztebl Int 2014, 111:83-91.
8. Siebenhofer A, Rakovac I, Kleespies C, Piso B, Didjurgeit U: Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thromb Haemost 2008, 100:1089-1098.
9. Siebenhofer A, Ulrich LR, Mergenthal K, Roehl I, Rauck S, Berghold A, Harder S, Gerlach FM, Petersen JJ: Primary care management for optimized antithrombotic treatment [PICANT]: study protocol for a cluster-randomized controlled trial. Implementation Sci 2012, 7:79.
10. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP: The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008, 61:344-349.
11. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schünemann HJ: Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 2012, 141:7S-47S.
12. Hirsh J, Fuster V, Ansell J, Halperin JL: American heart association/ American college of cardiology foundation guide to warfarin therapy. Circulation 2003, 107:1692-1711.
13. ∗ developed with the special contribution of the European heart rhythm association. Europace 2012, 14:1385-1413.
14. Nilsson GH, Björholt I, Johnsson H: Anticoagulant treatment in primary health care in Sweden - prevalence, incidence and treatment diagnosis: a retrospective study on electronic patient records in a registered population. BMC Fam Pract 2003, 4:3.
15. Schwabe U, Paffrath D: Arzneiverordnungs-Report 2013: Aktuelle Daten, Kosten, Trends und Kommentare. Berlin, Heidelberg: Springer Verlag; 2013.
16. Innasimuthu AL, Kumar S, Akter S, Borer JS: New oral anticoagulants: great promise for therapeutic advance but great knowledge gaps remain to be filled. Cardiology 2013, 126:41-49.
17. Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY: Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 2010, 123:638-645.e4.
18. Cowan C, Healicon R, Robson I, Long WR, Barrett J, Fay M, Tyndall K, Gale CP: The use of anticoagulants in the management of atrial fibrillation among general practices in England. Heart 2013, 99:1166-1172.
19. Wan Y, Heneghan C, Perera R, Roberts N, Hollowell J, Glasziou P, Bankhead C, Xu Y: Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circ Cardiovasc Qual Outcomes 2008, 1:84-91.
20. McBride D, Brüggenjürgen B, Roll S, Willich SN: Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice. J Thromb Thrombolysis 2007, 24:65-72.
21. Braun S, Völler H, Soppa C, Taborski U: Aktualisierte Leitlinie "Gerinnungsselbstmanagement". Dtsch Med Wochenschr 2009, 134:695-700.
22. Glasziou P, Irwig L, Mant D: Monitoring in chronic disease: a rational approach. BMJ 2005, 330:644-648.